{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:13:35Z","timestamp":1790748815820,"version":"4.1.0"},"reference-count":177,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00025","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:43:55Z","timestamp":1580258635000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Neuropsychiatric Disorders in Parkinson\u2019s Disease: What Do We Know About the Role of Dopaminergic and Non-dopaminergic Systems?"],"prefix":"10.3389","volume":"14","author":[{"given":"Kathy","family":"Dujardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Sgambato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson\u2019s disease: a population-based, prospective study.","volume":"48","author":"Aarsland","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","article-title":"Depression in Parkinson disease\u2013epidemiology, mechanisms and management.","volume":"8","author":"Aarsland","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1126\/science.1234733","article-title":"Repeated cortico-striatal stimulation generates persistent OCD-like behavior.","volume":"340","author":"Ahmari","year":"2013","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s002130050791","article-title":"Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.","volume":"140","author":"Ainsworth","year":"1998","journal-title":"Psychopharmacology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease.","volume":"88","author":"Antonini","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/s1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: risk factors and prevention.","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease.","volume":"27","author":"Ballanger","year":"2012","journal-title":"Mov. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1001\/archneurol.2010.35","article-title":"Serotonin 2A receptors and visual hallucinations in Parkinson disease.","volume":"67","author":"Ballanger","year":"2010","journal-title":"Arch. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"10340","DOI":"10.1523\/jneurosci.0895-11.2011","article-title":"Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior.","volume":"31","author":"Ballard","year":"2011","journal-title":"J. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/21556660.2019.1675670","article-title":"Risk factors for impulse control disorders and related behaviors in Parkinson\u2019s disease: secondary analyses of the ICARUS study.","volume":"8","author":"Barone","year":"2019","journal-title":"J. Drug Assess."},{"key":"B11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s1474-4422(10)70106-x","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2016.00587","article-title":"Preliminary evidence of apathetic-like behavior in aged vesicular monoamine transporter 2 deficient mice.","volume":"10","author":"Baumann","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/s0306-4522(99)00065-2","article-title":"Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat.","volume":"92","author":"Baunez","year":"1999","journal-title":"Neuroscience"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/brain\/awv183","article-title":"Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.","volume":"138","author":"Beaudoin-Gobert","year":"2015","journal-title":"Brain J. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/jnnp.2006.100073","article-title":"Cortical cholinergic denervation is associated with depressive symptoms in Parkinson\u2019s disease and parkinsonian dementia.","volume":"78","author":"Bohnen","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1002\/mds.22212","article-title":"Elevated serotonin transporter binding in depressed patients with Parkinson\u2019s disease: a preliminary PET study with [11C]DASB.","volume":"23","author":"Boileau","year":"2008","journal-title":"Mov. Disord."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions.","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson\u2019s disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"31","author":"Broen","year":"2016","journal-title":"Mov. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.04.025","article-title":"Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.","volume":"236","author":"Brown","year":"2012","journal-title":"Exp. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson\u2019s disease.","volume":"82","author":"Brown","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1126\/science.1232380","article-title":"Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors.","volume":"340","author":"Burgui\u00e8re","year":"2013","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/mds.21077","article-title":"Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson\u2019s disease.","volume":"21","author":"Burn","year":"2006","journal-title":"Mov. Disord."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2013.00175","article-title":"Rodent models of Parkinson\u2019s disease: beyond the motor symptomatology.","volume":"7","author":"Campos","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00047","article-title":"Depressive-like behavioral profiles in captive-bred single- and socially-housed rhesus and cynomolgus macaques: a species comparison.","volume":"8","author":"Camus","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.43","article-title":"Implication of dopamine D3 receptor activation in the reversion of Parkinson\u2019s disease-related motivational deficits.","volume":"4","author":"Carnicella","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/mds.25904","article-title":"Apathy in Parkinson\u2019s disease is associated with nucleus accumbens atrophy: a magnetic resonance imaging shape analysis.","volume":"29","author":"Carriere","year":"2014","journal-title":"Mov. Disord."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2017.00145","article-title":"Effect of levodopa on reward and impulsivity in a rat model of Parkinson\u2019s disease.","volume":"11","author":"Carvalho","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.expneurol.2015.09.002","article-title":"Depressive-like phenotype induced by AAV-mediated overexpression of human \u03b1-synuclein in midbrain dopaminergic neurons.","volume":"273","author":"Caudal","year":"2015","journal-title":"Exp. Neurol."},{"key":"B30","article-title":"Toxin-based rodent models of PD.","author":"Cenci","year":"2019","journal-title":"Neuromethods Ser."},{"key":"B31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1468-1331.2012.03878.x","article-title":"Mild affective symptoms in de novo Parkinson\u2019s disease patients: relationship with dopaminergic dysfunction.","volume":"20","author":"Ceravolo","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1176\/jnp.14.4.461","article-title":"Methylphenidate treats apathy in Parkinson\u2019s disease.","volume":"14","author":"Chatterjee","year":"2002","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management.","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.brainresbull.2011.01.005","article-title":"Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions.","volume":"84","author":"Chen","year":"","journal-title":"Brain Res. Bull."},{"key":"B35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.brainresbull.2011.05.009","article-title":"Alterations of emotion, cognition and firing activity of the basolateral nucleus of the amygdala after partial bilateral lesions of the nigrostriatal pathway in rats.","volume":"85","author":"Chen","year":"","journal-title":"Brain Res. Bull."},{"key":"B36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuropharm.2015.03.020","article-title":"Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson\u2019s disease.","volume":"95","author":"Chiu","year":"2015","journal-title":"Neuropharmacology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1080\/14656566.2016.1202917","article-title":"Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson\u2019s disease.","volume":"17","author":"Chung","year":"2016","journal-title":"Expert Opin. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/archneur.65.12.1604","article-title":"Functional abnormalities underlying pathological gambling in Parkinson disease.","volume":"65","author":"Cilia","year":"2008","journal-title":"Arch. Neurol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151884","article-title":"Multimodal MRI evaluation of the MitoPark mouse model of Parkinson\u2019s disease.","volume":"11","author":"Cong","year":"2016","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice.","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/mds.21949","article-title":"Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.","volume":"23","author":"Czernecki","year":"2008","journal-title":"Mov. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2016.04.049","article-title":"Time course study of microglial and behavioral alterations induced by 6-hydroxydopamine in rats.","volume":"622","author":"da Silva","year":"2016","journal-title":"Neurosci. Lett."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00437","article-title":"Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.","volume":"8","author":"Dardou","year":"2014","journal-title":"Front. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbr.2017.06.016","article-title":"Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area.","volume":"332","author":"Dardou","year":"2017","journal-title":"Behav. Brain Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1212\/wnl.0000000000000801","article-title":"Course of psychiatric symptoms and global cognition in early Parkinson disease.","volume":"83","author":"de la Riva","year":"2014","journal-title":"Neurology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"30","author":"den Brok","year":"2015","journal-title":"Mov. Disord."},{"key":"B47","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2013-306439","article-title":"Rivastigmine in apathetic but dementia and depression-free patients with Parkinson\u2019s disease: a double-blind, placebo-controlled, randomised clinical trial.","volume":"85","author":"Devos","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","article-title":"Hallucinations in Parkinson disease.","volume":"5","author":"Diederich","year":"2009","journal-title":"Nat. Rev. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mds.25937","article-title":"The clinical spectrum of anxiety in Parkinson\u2019s disease.","volume":"29","author":"Dissanayaka","year":"2014","journal-title":"Mov. Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/mp.2013.3","article-title":"Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson\u2019s disease.","volume":"19","author":"Drui","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01616412.2018.1493962","article-title":"Involvement of prelimbic 5-HT7 receptors in the regulation of anxiety-like behaviors in hemiparkinsonian rats.","volume":"109","author":"Du","year":"2018","journal-title":"Neurol. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/mds.26058","article-title":"Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms.","volume":"29","author":"Dujardin","year":"2014","journal-title":"Mov. Disord."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s11682-019-00185-6","article-title":"What can we learn from fMRI capture of visual hallucinations in Parkinson\u2019s disease?","author":"Dujardin","year":"2019","journal-title":"Brain Imaging Behav."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/mds.22843","article-title":"Apathy may herald cognitive decline and dementia in Parkinson\u2019s disease.","volume":"24","author":"Dujardin","year":"2009","journal-title":"Mov. Disord."},{"key":"B55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neuropharm.2016.05.013","article-title":"Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy.","volume":"109","author":"Engeln","year":"2016","journal-title":"Neuropharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.parkreldis.2012.05.022","article-title":"Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson\u2019s disease patients.","volume":"18","author":"Erro","year":"2012","journal-title":"Parkinson. Relat. Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/FBP.0b013e32833e7e80","article-title":"Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.","volume":"21","author":"Eskow Jaunarajs","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.nbd.2015.07.010","article-title":"The combined depletion of monoamines alters the effectiveness of subthalamic deep brain stimulation.","volume":"82","author":"Faggiani","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nbd.2017.11.001","article-title":"Serotonergic neurons mediate the anxiolytic effect of l-DOPA: neuronal correlates in the amygdala.","volume":"110","author":"Faggiani","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/mds.25837","article-title":"Pramipexole reverses Parkinson\u2019s disease-related motivational deficits in rats.","volume":"29","author":"Favier","year":"2014","journal-title":"Mov. Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson\u2019s disease.","volume":"289","author":"Fenelon","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors.","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain J. Neurol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/bs.irn.2017.04.005","article-title":"Psychosis in Parkinson\u2019s Disease.","volume":"133","author":"Ffytche","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1001\/archneur.63.9.1343","article-title":"Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.","volume":"63","author":"Fox","year":"2006","journal-title":"Arch. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1046\/j.1471-4159.1999.0722039.x","article-title":"A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study.","volume":"72","author":"Gambarana","year":"1999","journal-title":"J. Neurochem."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00351","article-title":"Impulse control disorders in Parkinson\u2019s disease. a brief and comprehensive review.","volume":"10","author":"Gatto","year":"2019","journal-title":"Front. Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.expneurol.2007.12.017","article-title":"Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour.","volume":"210","author":"George","year":"2008","journal-title":"Exp. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","article-title":"Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies.","volume":"68","author":"Giovannoni","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B69","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/wnl.45.4.669","article-title":"Mortality and hallucinations in nursing home patients with advanced Parkinson\u2019s disease.","volume":"45","author":"Goetz","year":"1995","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/mds.25554","article-title":"I finally see what you see: Parkinson\u2019s disease visual hallucinations captured with functional neuroimaging.","volume":"29","author":"Goetz","year":"2014","journal-title":"Mov. Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbr.2010.05.009","article-title":"Exercise effects on motor and affective behavior and catecholamine neurochemistry in the MPTP-lesioned mouse.","volume":"213","author":"Gorton","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/s0896-6273(00)00113-6","article-title":"Toward a neurobiology of obsessive-compulsive disorder.","volume":"28","author":"Graybiel","year":"2000","journal-title":"Neuron"},{"key":"B73","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/mds.27665","article-title":"Modifiable risk factors for cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies.","volume":"34","author":"Guo","year":"2019","journal-title":"Mov. Disord."},{"key":"B74","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuroscience.2014.10.008","article-title":"The place of dopamine in the cortico-basal ganglia circuit.","volume":"282","author":"Haber","year":"2014","journal-title":"Neuroscience"},{"key":"B75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.01.024","article-title":"Activation of serotonin(2C) receptors in the lateral habenular nucleus increases the expression of depression-related behaviors in the hemiparkinsonian rat.","volume":"93","author":"Han","year":"2015","journal-title":"Neuropharmacology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2016.05.016","article-title":"Serotonin7 receptors in the lateral habenular nucleus regulate depressive-like behaviors in the hemiparkinsonian rats.","volume":"1644","author":"Han","year":"2016","journal-title":"Brain Res."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0610-7","article-title":"Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson\u2019s disease.","volume":"16","author":"Hauser","year":"2016","journal-title":"BMC Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"E7395","DOI":"10.1073\/pnas.1705643114","article-title":"Separate mesocortical and mesolimbic pathways encode effort and reward learning signals.","volume":"114","author":"Hauser","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B79","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropsychologia.2017.07.003","article-title":"The anatomy of apathy: a neurocognitive framework for amotivated behaviour.","volume":"118","author":"Heron","year":"2018","journal-title":"Neuropsychologia"},{"key":"B80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pnpbp.2016.05.004","article-title":"Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson\u2019s disease.","volume":"70","author":"Holtz","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000345987","article-title":"Neuroimaging markers of motor and nonmotor features of Parkinson\u2019s disease: an 18f fluorodeoxyglucose positron emission computed tomography study.","volume":"35","author":"Huang","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"B82","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/fbp.0b013e3283656db6","article-title":"Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: evaluation of therapeutic ratios.","volume":"24","author":"Hubbard","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neuroscience.2014.03.033","article-title":"Activation of prelimbic 5-HT1A receptors produces antidepressant-like effects in a unilateral rat model of Parkinson\u2019s disease.","volume":"268","author":"Hui","year":"2014","journal-title":"Neuroscience"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s12035-018-1134-5","article-title":"Dopaminergic lesion in the olfactory bulb restores olfaction and induces depressive-like behaviors in a 6-OHDA model of Parkinson\u2019s disease.","volume":"56","author":"Ilkiw","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/wnl.0b013e3181c34b34","article-title":"Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study.","volume":"73","author":"Jeune","year":"2009","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neurobiolaging.2018.11.021","article-title":"Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson\u2019s disease.","volume":"75","author":"Jim\u00e9nez-Urbieta","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B87","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp-2017-316193","article-title":"Serotonin transporter binding and anxiety symptoms in Parkinson\u2019s disease.","volume":"89","author":"Joling","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mds.25543","article-title":"Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s Disease.","volume":"29","author":"Lee","year":"2014","journal-title":"Mov. Disord."},{"key":"B89","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/mds.23528","article-title":"Symptomatology and markers of anxiety disorders in Parkinson\u2019s disease: a cross-sectional study.","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov. Disord."},{"key":"B90","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.parkreldis.2008.04.007","article-title":"Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson\u2019s disease?","volume":"14","author":"Le Pen","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"B91","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/01616412.2019.1611204","article-title":"Activation and blockade of dorsal hippocampal Serotonin6 receptors regulate anxiety-like behaviors in a unilateral 6-hydroxydopamine rat model of Parkinson\u2019s disease.","volume":"41","author":"Liu","year":"2019","journal-title":"Neurol. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.neuropharm.2015.03.031","article-title":"Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson\u2019s rats.","volume":"95","author":"Liu","year":"2015","journal-title":"Neuropharmacology"},{"key":"B93","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbr.2018.12.007","article-title":"Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson\u2019s disease.","volume":"360","author":"Loiodice","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.brainresbull.2014.11.006","article-title":"Lateral habenula as a link between dopaminergic and serotonergic systems contributes to depressive symptoms in Parkinson\u2019s disease.","volume":"110","author":"Luo","year":"2015","journal-title":"Brain Res. Bull."},{"key":"B95","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162","article-title":"The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease.","volume":"139","author":"Maillet","year":"2016","journal-title":"Brain J. Neurol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1176\/jnp.3.3.243","article-title":"Apathy: a neuropsychiatric syndrome.","volume":"3","author":"Marin","year":"1991","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1053\/scnp00100304","article-title":"Apathy: concept, syndrome, neural mechanisms, and treatment.","volume":"1","author":"Marin","year":"1996","journal-title":"Semin. Clin. Neuropsychiatry"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1007\/s12035-015-9330-z","article-title":"Temporal dissociation of striatum and prefrontal cortex uncouples anhedonia and defense behaviors relevant to depression in 6-OHDA-lesioned rats.","volume":"53","author":"Matheus","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/fbp.0b013e32834aff98","article-title":"Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson\u2019s disease.","volume":"22","author":"McFarland","year":"2011","journal-title":"Behav. Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbr.2014.07.055","article-title":"Dopamine receptor D3 deficiency results in chronic depression and anxiety.","volume":"274","author":"Moraga-Amaro","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice.","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci. Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2011.06.056","article-title":"Increased dopamine transporter density in Parkinson\u2019s disease patients with social anxiety disorder.","volume":"310","author":"Moriyama","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/hmg\/ddu748","article-title":"Early Parkinson\u2019s disease symptoms in \u03b1-synuclein transgenic monkeys.","volume":"24","author":"Niu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"B104","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbr.2015.12.045","article-title":"Investigation of diazepam efficacy on anxiety-like behavior in hemiparkinsonian rats.","volume":"301","author":"O\u2019Connor","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14802\/jmd.15041","article-title":"Effect of rivastigmine on behavioral and psychiatric symptoms of Parkinson\u2019s disease dementia.","volume":"8","author":"Oh","year":"2015","journal-title":"J. Mov. Disord."},{"key":"B106","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1212\/WNL.58.suppl_1.S63","article-title":"Depression associated with Parkinson\u2019s disease: clinical features and treatment.","volume":"58","author":"Okun","year":"2002","journal-title":"Neurology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/mds.23016","article-title":"Excessive hoarding in Parkinson\u2019s disease.","volume":"25","author":"O\u2019Sullivan","year":"2010","journal-title":"Mov. Disord."},{"key":"B108","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson\u2019s disease patients, even from the premotor phase.","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov. Disord."},{"key":"B109","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00415-009-5297-x","article-title":"Apathy in drug-na\u00efve patients with incident Parkinson\u2019s disease: the Norwegian ParkWest study.","volume":"257","author":"Pedersen","year":"2009","journal-title":"J. Neurol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.02.010","article-title":"Association between dopaminergic dysfunction and anxiety in de novo Parkinson\u2019s disease.","volume":"37","author":"Picillo","year":"2017","journal-title":"Parkinson. Relat. Disord."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/wnl.0b013e3181feb2ab","article-title":"Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures.","volume":"75","author":"Politis","year":"2010","journal-title":"Neurology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/mds.22611","article-title":"Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson\u2019s disease.","volume":"24","author":"Pontone","year":"2009","journal-title":"Mov. Disord."},{"key":"B113","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments.","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mds.27793","article-title":"Early limbic microstructural alterations in apathy and depression in de novo Parkinson\u2019s disease.","volume":"34","author":"Prange","year":"2019","journal-title":"Mov. Disord."},{"key":"B115","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","article-title":"The impact of depressive symptoms in early Parkinson disease.","volume":"69","author":"Ravina","year":"","journal-title":"Neurology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group.","volume":"22","author":"Ravina","year":"","journal-title":"Mov. Disord."},{"key":"B117","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease.","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov. Disord."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1002\/mds.23268","article-title":"Neuroanatomical correlates of apathy in Parkinson\u2019s disease: a magnetic resonance imaging study using voxel-based morphometry.","volume":"25","author":"Reijnders","year":"2010","journal-title":"Mov. Disord."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system.","volume":"128","author":"Remy","year":"2005","journal-title":"Brain J. Neurol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","article-title":"Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease.","volume":"257","author":"Riedel","year":"2010","journal-title":"J. Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1212\/wnl.0b013e3182698c75","article-title":"Apathy in patients with Parkinson disease without dementia or depression: a PET study.","volume":"79","author":"Robert","year":"2012","journal-title":"Neurology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1212\/wnl.0000000000000941","article-title":"Preoperative factors of apathy in subthalamic stimulated Parkinson disease: a PET study.","volume":"83","author":"Robert","year":"2014","journal-title":"Neurology"},{"key":"B123","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.eurpsy.2018.07.008","article-title":"Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group.","volume":"54","author":"Robert","year":"2018","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine.","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease.","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00702-018-1871-7","article-title":"Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers.","volume":"125","author":"Sgambato","year":"2018","journal-title":"J. Neural Trans."},{"key":"B127","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00429-014-0911-9","article-title":"Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates.","volume":"221","author":"Sgambato-Faure","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1136\/jnnp-2012-303391","article-title":"Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson\u2019s disease.","volume":"83","author":"Shin","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B129","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mds.24900","article-title":"Investigating visual misperceptions in Parkinson\u2019s disease: a novel behavioral paradigm.","volume":"27","author":"Shine","year":"2012","journal-title":"Mov. Disord."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2015.3","article-title":"Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson\u2019s disease: a task-based fMRI study.","volume":"1","author":"Shine","year":"2015","journal-title":"NPJ Parkinsons Dis."},{"key":"B131","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/mds.23508","article-title":"The prevalence and clinical characteristics of punding in Parkinson\u2019s disease.","volume":"26","author":"Spencer","year":"2011","journal-title":"Mov. Disord."},{"key":"B132","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/mdc3.12507","article-title":"Management of depression in Parkinson\u2019s disease: a systematic review.","volume":"4","author":"Starkstein","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","article-title":"Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.","volume":"132","author":"Steeves","year":"2009","journal-title":"Brain J. Neurol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuropharm.2015.03.007","article-title":"Activation of 5-HT1A receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson\u2019s disease.","volume":"95","author":"Sun","year":"2015","journal-title":"Neuropharmacology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.neuropharm.2018.05.016","article-title":"Activation and blockade of basolateral amygdala 5-HT6 receptor produce anxiolytic-like behaviors in an experimental model of Parkinson\u2019s disease.","volume":"137","author":"Sun","year":"2018","journal-title":"Neuropharmacology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pbb.2009.12.020","article-title":"MPTP-induced dopaminergic degeneration and deficits in object recognition in rats are accompanied by neuroinflammation in the hippocampus.","volume":"95","author":"Sy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B137","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson\u2019s disease.","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"B138","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.1523\/jneurosci.1495-09.2009","article-title":"Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity.","volume":"29","author":"Taylor","year":"2009","journal-title":"J. Neurosci."},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122063","article-title":"Dopaminergic lesions of the dorsolateral striatum in rats increase delay discounting in an impulsive choice task.","volume":"10","author":"Tedford","year":"2015","journal-title":"PLoS One"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: predictors and underlying mesolimbic denervation.","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain J. Neurol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds to dopaminergic stimulation of D2\/D3 receptors with piribedil.","volume":"136","author":"Thobois","year":"2013","journal-title":"Brain J. Neurol."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132064","article-title":"Neuroimaging analysis of the dopamine basis for apathetic behaviors in an MPTP-lesioned primate model.","volume":"10","author":"Tian","year":"2015","journal-title":"PLoS One"},{"key":"B143","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/mds.23453","article-title":"Focal cortical and subcortical atrophy in early Parkinson\u2019s disease.","volume":"26","author":"Tinaz","year":"2011","journal-title":"Mov. Disord."},{"key":"B144","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.parkreldis.2015.05.016","article-title":"Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson\u2019s disease are associated with nonmotor symptoms.","volume":"21","author":"Tong","year":"2015","journal-title":"Parkinson. Relat. Disord."},{"key":"B145","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0079-6123(10)84005-1","article-title":"Viral vector-mediated overexpression of \u03b1-synuclein as a progressive model of Parkinson\u2019s disease.","volume":"184","author":"Ulusoy","year":"2010","journal-title":"Prog. Brain Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2017.12.041","article-title":"Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: therapeutic implications for Parkinson\u2019s disease.","volume":"342","author":"Vecchia","year":"2018","journal-title":"Behav. Brain Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/mds.21073","article-title":"Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson\u2019s disease.","volume":"21","author":"Visanji","year":"2006","journal-title":"Mov. Disord."},{"key":"B148","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s1474-4422(17)30004-2","article-title":"Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update.","volume":"16","author":"Voon","year":"2017","journal-title":"Lancet Neurol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neuron.2009.12.027","article-title":"Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors.","volume":"65","author":"Voon","year":"2010","journal-title":"Neuron"},{"key":"B150","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","article-title":"Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels.","volume":"85","author":"Voon","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B151","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/jnnp-2015-310383","article-title":"A smaller amygdala is associated with anxiety in Parkinson\u2019s disease: a combined FreeSurfer-VBM study.","volume":"87","author":"Vriend","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B152","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2013.11.001","article-title":"Depression and impulse control disorders in Parkinson\u2019s disease: two sides of the same coin?","volume":"38","author":"Vriend","year":"","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B153","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304811","article-title":"Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus.","volume":"85","author":"Vriend","year":"","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B154","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","article-title":"Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.","volume":"32","author":"Vuckovic","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"B155","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuropharm.2017.01.015","article-title":"Involvement of lateral habenula \u03b11 subunit-containing GABAA receptor-mediated inhibitory transmission in the regulation of depression-related behaviors in experimental Parkinson\u2019s disease.","volume":"116","author":"Wang","year":"2017","journal-title":"Neuropharmacology"},{"key":"B156","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neulet.2017.05.062","article-title":"Cerebral metabolic change in Parkinson\u2019s disease patients with anxiety: a FDG-PET study.","volume":"653","author":"Wang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1037\/a0017401","article-title":"MPTP lesion causes neuroinflammation and deficits in object recognition in Wistar rats.","volume":"123","author":"Wang","year":"2009","journal-title":"Behav. Neurosci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2016.10.021","article-title":"Neural correlates of anxiety symptoms in mild Parkinson\u2019s disease: a prospective longitudinal voxel-based morphometry study.","volume":"371","author":"Wee","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B159","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson\u2019s disease.","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson\u2019s disease.","volume":"30","author":"Weintraub","year":"","journal-title":"Mov. Disord."},{"key":"B161","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.","volume":"67","author":"Weintraub","year":"","journal-title":"Arch. Neurol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1212\/wnl.0b013e3181ebdd79","article-title":"Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.","volume":"75","author":"Weintraub","year":"","journal-title":"Neurology"},{"key":"B163","first-page":"227","article-title":"Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease.","volume":"46","author":"Weintraub","year":"2005","journal-title":"J. Nucl. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1212\/wnl.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"key":"B165","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson\u2019s disease.","volume":"30","author":"Weintraub","year":"","journal-title":"Mov. Disord."},{"key":"B166","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/1060028017703992","article-title":"Evidence-based review of pharmacotherapy used for Parkinson\u2019s disease psychosis.","volume":"51","author":"Wilby","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"B167","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2007.10.020","article-title":"High frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole-induced compulsive checking behavior in rats.","volume":"210","author":"Winter","year":"2008","journal-title":"Exp. Neurol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.bbr.2007.07.002","article-title":"Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.","volume":"184","author":"Winter","year":"2007","journal-title":"Behav. Brain Res."},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00263","article-title":"Fifty percent prevalence of extracampine hallucinations in Parkinson\u2019s disease patients.","volume":"6","author":"Wood","year":"2015","journal-title":"Front. Neurol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1002\/hbm.22577","article-title":"The default mode network is disrupted in Parkinson\u2019s disease with visual hallucinations.","volume":"35","author":"Yao","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"B171","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00429-014-0907-5","article-title":"Multimodal MRI of the hippocampus in Parkinson\u2019s disease with visual hallucinations.","volume":"221","author":"Yao","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"B172","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.parkreldis.2014.11.020","article-title":"Resting activity in visual and corticostriatal pathways in Parkinson\u2019s disease with hallucinations.","volume":"21","author":"Yao","year":"2015","journal-title":"Parkinson. Relat. Disord."},{"key":"B173","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neuroscience.2015.10.016","article-title":"Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced Parkinson\u2019s disease rat model.","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"B174","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00213-011-2356-7","article-title":"Antidepressant-like properties of sarizotan in experimental Parkinsonism.","volume":"218","author":"Zhang","year":"2011","journal-title":"Psychopharmacology"},{"key":"B175","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4077\/cjp.2018.bah588","article-title":"Serotonin6 receptors in the prelimbic cortex are involved in the regulation of anxiety-like behaviors in the rat 6-hydroxydopamine Parkinson\u2019s disease model.","volume":"61","author":"Zhang","year":"2018","journal-title":"Chin. J. Physiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neuropharm.2016.07.014","article-title":"Activation and blockade of prelimbic 5-HT6 receptors produce different effects on depressive-like behaviors in unilateral 6-hydroxydopamine-induced Parkinson\u2019s rats.","volume":"110","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1111\/j.1460-9568.2007.05812.x","article-title":"Non-motor behavioural impairments in parkin-deficient mice.","volume":"26","author":"Zhu","year":"2007","journal-title":"Eur. J. Neurosci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00025\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:43:59Z","timestamp":1580258639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00025\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":177,"alternative-id":["10.3389\/fnins.2020.00025"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00025","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"article-number":"25"}}